Company news
Ocular Therapeutix, Inc. news in 2019
Ocular Therapeutix, Inc.'s news releases, calls and decks from 2019, newest first.
Ocular Therapeutix Announces Strategic Update and Operational Restructuring
November 7, 2019
Ocular Therapeutix™ To Report Third Quarter 2019 Financial Results
November 4, 2019
Ocular Therapeutix Announces Permanent J-Code for DEXTENZA® (dexamethasone ophthalmic insert) Effective October 1, 2019
September 30, 2019
Ocular Therapeutix™ Announces First Patient Dosed in Phase 3 Clinical Trial of DEXTENZA® for the Treatment of Allergic Conjunctivitis
September 23, 2019